Medical Cannabis Property Developer Initiates Private Placement for Massachusetts Development

DENVER, CO / ACCESSWIRE / July 29, 2016 / AmeriCann, Inc. (OTCQX: ACAN), a company that designs and plans to develop and lease sustainable, state-of-the-art medical cannabis cultivation properties, has engaged a Colorado-based investment banking firm to commence a $5 million secured convertible note offering.

The company plans to use the proceeds from the offering to purchase land and to prepare for construction of its large-scale, sustainable medical cannabis production facility known as the Massachusetts Medical Cannabis Center (MMCC) to be built 47 miles from Boston. The company does not cultivate, process, distribute or sell cannabis. This business model provides AmeriCann greater flexibility to pursue national and international development opportunities.

“Our energy efficient sustainable cultivation facilities are designed to deliver the best quality, consistent cannabis-based medicine that patients need and deserve,” said Tim Keogh, President and CEO of AmeriCann. “Our goal is to set a new standard for the industry with better products, reduced energy and water use and overall efficiency.”

The Company has signed a definitive agreement with Coastal Compassion Inc., one of a limited number of licensed cannabis operators in Massachusetts. The MMCC development is planned to serve the rapidly growing Massachusetts medical cannabis program, widely regarded as among the most attractive in the national cannabis industry. Coastal Compassion, Inc. will become MMCC’s initial tenant upon completion of the first phase of 130,000 square feet, with one additional building location available to another licensed Massachusetts cannabis operator.

AmeriCann’s 506(c) Private Offering provides accredited investors the opportunity to participate in one of the fastest growing industries, with an attractive yield that is secured by real estate.

AmeriCann is offering Secured Convertible Promissory Notes at a price of $25,000 per Unit for a total of $5,000,000.

Each Unit Includes:

A $25,000 Note from AmeriCann, Inc.
9.5% annual interest paid quarterly
36-month maturity
Secured by a first lien on a 52.6-acre land parcel
Rights to convert Note into 20,000 shares of AmeriCann common stock ($1.25 per share)
Series I Warrants to purchase 20,000 shares at $1.50 per share
Series II Warrants to purchase 20,000 shares at $3.00 per share

Accredited Investors, under Rule 506(c) of Regulation D promulgated by the SEC under the Securities Act of 1933, must meet standards created by the SEC for annual income and net worth. AmeriCann, Inc.’s public stock is listed on the OTCQX Market under the symbol ACAN.

Industry experts believe the legal cannabis industry will grow from $5.4 billion in revenue in 2015 to over $22 billion by 2020. Additionally, up to 12 states are expected to have initiatives approving medical or adult use cannabis on the ballot on November 8.

Massachusetts voters will have the opportunity to vote on Ballot Measure 4, the “Legalization, Regulation and Taxation of Marijuana,” on November 8, 2016.

GVC Capital, a FINRA registered investment banking firm, is acting as the Placement Agent for the offering.

About AmeriCann

AmeriCann is a publicly traded company that designs and plans to develop and lease sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. AmeriCann has preferred partners in Colorado, Massachusetts and Delaware. AmeriCann does not cultivate, process or distribute cannabis, but partners with local businesses to serve marijuana patients in their communities.

AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company’s commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: www.americann.co.

About GVC Capital

GVC Capital LLC is an innovative investment-banking firm headquartered in the Denver suburb of Greenwood Village, Colorado. It focuses primarily on providing comprehensive investment banking services to underexposed and undervalued microcap companies. GVC Capital is committed to a simple operating philosophy: provide exceptional emerging companies with the financial and professional resources necessary to achieve long-term goals, fulfill outstanding potential, and maximize shareholder value.

For additional information on the offering or to request offering documents contact GVC Capital at:

GVC Capital: (720) 488-4702
Email: acan@gvccap.com

Member: FINRA/SIPC

The securities offered by AmeriCann have not been registered under the Securities Act or the securities laws of any state of the United States and may not be offered or sold in the United States absent such registration or an applicable exemption from such registration requirements. Additional details of the offering, including the Company’s Corporate Presentation, are available for viewing by accredited investors at www.americann.co. Also, for additional information on the company and to request documents for the offering, please email acan@gvccap.com or call 720-488-4702.

This press release does not constitute an offer to sell or a solicitation of an offer to buy AmeriCann’s securities nor shall there be any sale of the securities referenced herein in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. The securities referenced herein have not been approved or disapproved by any regulatory authority.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K for the year ended September 30, 2015, which the Company has filed with the SEC and which may be viewed at http://www.sec.gov.

Contact Information:

AmeriCann, Inc.
3200 Brighton Blvd. Unit 114
Denver, CO 80216
(303) 862-9000
info@americann.co
www.americann.co

SOURCE: AmeriCann, Inc.

ReleaseID: 442984

ZURICH, SWITZERLAND / ACCESSWIRE / July 29, 2016 / Today, Stephan Bogner from Rockstone Research published an initiating coverage report on Pistol Bay Mining Inc. (TSX.V: PST).

When initiating coverage on Golden Dawn Minerals Inc. 2 weeks ago, the stock traded at $0.16 CAD (today at $0.39 CAD). When initiating coverage on Aurvista Gold Corp. in May, the stock traded at $0.23 CAD (today at $0.30 CAD). Obviously, the early bird catches the worm. Pistol Bay Mining Inc. has nearly 14 million shares issued and outstanding, and a current market capitalization of less than $750.000 CAD.

According to the company, other worthwile projects are presently seeked to create shareholder value. Once the ongoing financing has been closed, some of the proceeds are expected to be invested into its 100% owned Dixie Zinc-Copper Project in the prolific Red Lake Mining District of Ontario. This project was acquired already last year, when the commodity markets were culminating in its depressed state, hence it may turn out as a superb bargain (especially when exploration starts and succeeds). Of all commodities, zinc enjoys one of the most positive fundamentals for higher prices going forward and appreciated by almost 50% so far in 2016.

On top of that, Pistol Bay owns the 3 uranium projects C4, C5 and C6 in the Athabasca Basin of Saskatchewan, located adjacent to the Wheeler River / Phoenix Deposits of Denison Mines Corp. and Cameco Corp. Pistol Bay optioned this project to Rio Tinto Exploration Canada Uranium Corp., who informed the company that they will continue exploration on this property in 2016. Rio Tinto previously announced its intention to exercise its option to acquire 100% interest by paying $5 million CAD within the next 3.5 years and granting a 5% net profits interest to Pistol Bay.

The full report can be accessed with the following links:

English (PDF):

http://rockstone-research.com/images/PDF/PistolBay1en.pdf

English (web version):

http://rockstone-research.com/index.php/en/research-reports/1388-Early-Bird-Special-Report:-Pistol-Bay-with-Zinc-like-a-Phoenix-from-the-Ashes

German (PDF):

http://rockstone-research.com/images/PDF/PistolBay1de.pdf

Disclaimer:
Please read the full disclaimer within the full research report as a PDF as
fundamental risks and conflicts of interest exist.

SOURCE: Rockstone Research

ReleaseID: 443002

NEW YORK, NY / ACCESSWIRE / July 29, 2016 / Soupman, Inc. (OTCQB: SOUP), makers of fabulous gourmet soup made famous on “Seinfeld”, today announced that it has completed a private placement with one institutional investor of a Senior Secured Convertible Debenture for gross proceeds of $3.0 million. Soupman will use the bulk of the net proceeds from the transaction to purchase inventory to meet strong order demand from national supermarket chains. The balance of the proceeds will be applied to working capital.

The Debenture bears annual interest at 8% matures on April 1, 2018 and is convertible into Soupman common stock at a fixed rate of $.02 per share, subject to a customary 4.99% cap tied to Company’s currently outstanding shares of common stock. Chardan Capital Markets, LLC acted as the exclusive placement agent for this transaction.

Jamie Karson, Soupman’s Chairman and CEO, stated, “We are very thankful to our existing investors for their support and our new investor for their vote of confidence. We believe that with the closing of this transaction, we will be able to meaningfully drive revenues and profits to meet our near term and longer term milestones.”

About Soupman, Inc.

The Original Soupman® offers over 50 varieties of soups including such famous flavors as Lobster Bisque, Crab Bisque, Chicken Gumbo, Crab Corn Chowder, Mulligatawny, Butternut Squash, Jambalaya, Shrimp Bisque, Italian Sausage, Eggplant Parmigiana, Tomato Basil and many more. The Original Soupman® soups are also available in 6 varieties in 17 ounce Tetra Pak cartons in grocery stores including Publix, Kroger, Ralph’s, Vons, Pavilions, HEB and Safeway among many others. The soups can also be ordered online and at Amazon.com. For a store tracker or to order, go to www.originalsoupman.com.

Consumers can visit the Soupman at his original store in NYC on 55 Street & 8th Ave, on soupmobiles at local events throughout the nation and ladling soup for fans at MetLife stadium during the football season.

In 1984, The Original Soupman opened its doors at 55th Street & 8th Avenue in Manhattan and quickly became a worldwide destination. Rated #1 by Zagat and praised by the New York Times as “Art, not Soup,” it set the standard for innovation and excellence long before the famous “Seinfeld” episode made it a cultural icon. We sell soup across America in Tetra Pak cartons to grocery stores next to Campbell’s and Progresso as well in our franchise restaurants, soupmobiles and through foodservice companies. Jamieson Karson, former CEO of Steven Madden, LTD., is our Chairman and CEO. Steve Madden, Tim Gannon and Reggie Jackson are on our Board of Advisors. Soupman Inc., is a fully reporting public company trading on the OTCQB under the symbol SOUP. For additional information on our company please visit:
www.originalsoupman.com, Twitter@OriginalSoupMan and “Like” us on Facebook.

Safe Harbor Statement:

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The forward-looking statements are based on current expectations, estimates and projections made by management. The Company intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as “anticipates”, “expects”, “intends”, “plans”, “believes”, “seeks”, “estimates” or variations of such words are intended to identify such forward-looking statements. The forward-looking statements contained in this press release include, statements regarding driving revenues and profits to meet our near term and longer term milestones. All forward-looking statements in this press release are made as of the date of this press release, and the Company assumes no obligation to update these forward-looking statements other than as required by law. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements such as our ability to continue to reduce liabilities and expand our product line and distribution, our ability to execute our business strategy and position the Company for future growth, and the risk factors discussed in the Business and Management’s Discussion and Analysis sections in our Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K. Copies of these filings are available
www.originalsoupman.com.

All trademarks and logos referenced herein belong to their respective companies.

For Additional Information:

Soupman Inc.
Robert N. Bertrand
President & CFO
212-768-7687

SOURCE: Soupman, Inc.

ReleaseID: 442985

Loftus Hopes to Raise Enough Money to Move Her Small-Scale Coffee Roaster into New and More Spacious Digs

LOS ANGELES, CA / ACCESSWIRE / July 29, 2016 / Amelia Loftus, founder of Hidden Fortress, a small-scale, solar-powered coffee roaster, is pleased to announce her intentions to move her successful coffee operation into a larger space. Calling her project Build the Hidden Fortress Roastery Cafe, Loftus is currently trying to raise money for the beautiful and conveniently located new building in Watsonville, California.

To learn more about the Hidden Fortress and Loftus’ plans to bring her delicious and organically grown coffee into the appreciative hands of as many people as possible, please visit https://goo.gl/Db9d2Y.

As Loftus noted, she founded Hidden Fortress in 2012 and operates the business full time. She has roasted coffee since 2000, and is extremely knowledgeable about what it takes to create delicious, organic and sustainably grown coffee.

“Our primary sales outlet has been our farmer’s market coffee booth, which is also solar powered,” Loftus said.

“Our coffee business has grown steadily over 3 years and we have outgrown the 2 pound solar and propane powered coffee roasting machine we use.”

While Loftus is excited to expand her coffee roasting operation into a much bigger leased space in Watsonville, she also understands that achieving this goal will take a great deal of money. This inspired her to launch a fundraising campaign on Kickstarter. Loftus hopes to raise $25,000 through crowdfunding in order to move into her new space as soon as possible.

“Our location is next to a business park where many large local work places such as Granite Construction, Nordic Naturals, the community hospital, and Foxx Racing Shox are located,” she said, adding that it is a central location with easy freeway access, ideal for drop in visitors and is a great launching point for her and her husband to get to the farmer’s markets.

“The plans include the installation of 2 small roasters, and a full food prep kitchen area so we can make fresh lemonade and syrups for our coffee bar.”

About Hidden Fortress Roastery Cafe:

Amelia Loftus founded Hidden Fortress in 2012 and operates the business full time. This includes keeping up the farm with help from her husband, Patrick. The couple roasts organic coffee at their farm and sells it at farmer’s markets. They are about to build their roastery cafe and need a cash boost to finish. For more information, please visit https://goo.gl/Db9d2Y.

Contact:

Adrienne Brown

admin@rocketfactor.com

(949) 555-2861

SOURCE: Hidden Fortress Roastery Cafe

ReleaseID: 442991

Salt Payments Will Add OfferProphet to its Lime Light CRM System

LOS ANGELES, CA / ACCESSWIRE / July 29, 2016 / HaloRiver, LLC, an industry-leading performance marketing campaign management agency, is pleased to announce that it has just sold its OfferProphet ecommerce continuity based reporting and analytics system to Salt Payments. Salt Payments plans on including OfferProphet into their Lime Light CRM system.

As company spokesperson Nate Lind noted, Lime Light CRM is one of today’s leading and most trusted providers of continuity based processing and campaign management. This important acquisition, combined with the industry-leading experience and leadership of HaloRiver’s management team, puts Lime Light CRM at the forefront of the continuity based processing and campaign management systems.

“We’re excited to sell our reporting and analytics platform to Salt. Business intelligence, analytics and key performance indicator reporting is absolutely critical to the success of any online merchants. I don’t know how any online continuity based merchant can confidently sell products to consumers without the detail and analysis included in the OfferProphet system,” said Lind, Managing Member and Co-Founder of HaloRiver.

“With the additional userbase that the Limelight system brings and the additional analytics that OfferProphet brings, the continuity industry just got a huge upgrade. That upgrade will ultimately lead to more profit and less risk for the Lime Light customers,” said Lind.

Lime Light CRM’s industry-leading number of integrations with key third party providers, along with Lind and his team’s continued support of the integration, rollout and additional development of new KPIs will allow direct response advertisers to connect with all of the systems and parties they need. In addition, they will now be able to watch the performance of their campaigns with unparalleled precision.

With this dedication to creating innovative solutions for merchants and direct response advertisers, Lime Light CRM further strengthens its position as an industry leader.

About HaloRiver, LLC and OfferProphet:

HaloRiver, LLC, an industry-leading performance marketing campaign management agency headquartered in Rio Rancho, New Mexico. Lime Light CRM helps marketers streamline the creation and management of direct marketing campaigns, generating high volume transactions across multiple countries, and accepting most major currencies. For more information, please visit http://www.offerprophet.com/ and https://www.limelightcrm.com/.

Contact:

Clarence Houston

admin@rocketfactor.com

(949) 555-2861

SOURCE: HaloRiver, LLC

ReleaseID: 442990

MIAMI, FL / ACCESSWIRE / July 29, 2016 / EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on DSG Global, Inc. (OTCQB: DSGT)

DSG Global Inc. (OTCQB: DSGT), new to EmergingGrowth.com is thriving in the $38 billion cloud based Infrastructure as a Service (IaaS) and Software as a Service (SaaS) industry.

See the Full Report on DSG Global Inc. (OTCQB: DSGT) at EmergingGrowth.com

http://emerginggrowth.com/dsg-global-inc-otcqb-dsgt-partners-with-sprint-corp-nyse-s-rapid-expansion/

DSG Global Inc. (OTCQB: DSGT) partnered with Sprint Corp (NYSE: S) assisting with the tablet connectivity across its DSG TAG Systems platform. The understanding is that Sprint will provide cellular and data account coverage for DSG Global Inc. (OTCQB: DSGT)’s line of tablets and TAGS that are located in each golf cart and turf care products.

As of July 2016, DSG Global Inc (OTCQB: DSGT) had its TAG System deployed to just under 300 golf courses around the world. Furthermore, the company is forecasting to have approximately another 100 courses signed up and using its fleet management system by the end of 2016.

See the full report on EmergingGrowth.com as well as a recap of what’s causing its Boom here:

http://emerginggrowth.com/emerginggrowth-com-spotlight-friendable-user-session-times-exceed-industry-average/

About
DSG Global, Inc.:

DSG Global Inc. (OTCQB: DSGT) operates as a technology services company and offers GPS-based fleet management solutions. Through the DSG TAG System, DSG Global Inc. (OTCQB: DSGT) offers an infrastructure as a service (IaaS) product that combines hardware and software components to assist in fleet management and vehicle control systems across a variety of industries. However, DSG Global Inc. (OTCQB: DSGT) currently is heavily focused and concentrated on the golf industry.

About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

Disclaimer

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. Full details about which can be found in our full disclosure, which can be found here, http://www.emerginggrowth.com/disclosure-3748 Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

CONTACT:

Company: EmergingGrowth.com – http://www.EmergingGrowth.com
Contact Email: EmergingGrowth1@gmail.com

SOURCE:EmergingGrowth.com

ReleaseID: 442982

TORONTO, ON / ACCESSWIRE / July 29, 2016 / Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTC: TLTFF), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the development of Photo Dynamic Compounds (“PDCs”) to destroy cancer, announced today that it has filed an Investigational Testing Authorization (“ITA”) with Health Canada for approval to use its patent pending TLC-3200 Photo Dynamic Therapy (“PDT”) Laser System and TLC-34XX Dosimetry Fibre Optic Cage (“DFOC”) technology, in conjunction with its Clinical Trial Application (“CTA”) approved lead PDC, TLD-1433, in a Phase Ib clinical trial for the treatment of Non-Muscle Invasive Bladder Cancer (“NMIBC”).

The TLC-3200 PDT Laser System delivers green laser light, at a wavelength of 525 nanometers (“nm”), while the DFOC technology precisely monitors the laser light to provide a uniform distribution of the laser light energy, in the correct dosage, to the bladder wall.

The clinical procedure for the Phase Ib study to treat NMIBC, titled “A Phase Ib Trial of Intravesical Photodynamic Therapy in Patients with Non-Muscle Invasive Bladder Cancer at High Risk of Progression Who are Refractory to Therapy with Bacillus Calmette-Guerin (“BCG”) and Who are Medically Unfit For or Refuse a Cystectomy” is to:

Intravesically instill a sterile water based solution of TLD-1433 via catheter, through the urethra, into the bladder of a patient inflicted with NMIBC, who has failed standard of care and who is not indicated or refuses to have their bladder removed
Allow the solution of TLD-1433 to absorb into any resident bladder cancer tumours for approximately sixty minutes
Void the bladder and flush the bladder twice with sterile water to remove any excess TLD-1433 solution not absorbed by any bladder tumours
Admit the patient into the operating room and administer a general anesthetic
Insert a rigid cystoscope through the urethra of the patient into the bladder
Fill the bladder with sterile water to provide shape to the bladder
Insert the TLC-34XX DFOC device into the bladder via the cystoscope’s working channel and connect it to the TLC-3200 PDT Laser System
Deploy the DFOC in the bladder (like an umbrella) to strategically place optical detectors at twelve (12) predetermined locations along the bladder wall to precisely monitor the laser light to provide a uniform distribution of the laser light energy, in the correct dosage, to the bladder wall

Pending Health Canada approval of the ITA, Theralase will immediately commence enrollment of patients into a Phase Ib clinical study in the treatment of NMIBC. The primary outcome measures of the Phase Ib clinical study will be safety and tolerability, with a secondary outcome measure of pharmacokinetics (where the drug accumulates in tissue and how it exits the body) and an exploratory outcome measure of efficacy.

Roger Dumoulin-White, President and CEO of Theralase stated that, “The Company and its team of dedicated professionals have worked tirelessly over the last 7 months to design, optimize, test and manufacture the hardware and software of the TLC-3200 PDT Laser System and the TLC-34XX DFOC technology and to compile the data for a Health Canada ITA application, providing support for claims of: biocompatibility, sterility, electrical safety, functionality and mechanical integrity of the technology. We look forward to a favourable and timely review by Health Canada to allow us the ability to commence the Phase Ib clinical study for NMIBC.”

About Theralase Technologies Inc.

Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTC: TLTFF) in its Therapeutic Laser Technology (“TLT”) Division designs, manufactures, markets and distributes patented super-pulsed
laser technology indicated for the: elimination of pain, reduction of inflammation and dramatic acceleration of tissue healing for numerous nerve, muscle and joint conditions. Theralase’s Photo Dynamic Therapy (“PDT”) Division researches and develops specially designed molecules called Photo
Dynamic Compounds (“PDCs”), which are able to localize to cancer cells and then when laser light activated, effectively destroy them.

Additional information is available at www.theralase.com and www.sedar.com.

This press release contains forward-looking statements, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

For More Information:

Roger Dumoulin-White
President & CEO
1.866.THE.LASE (843-5273) ext. 225
416.699.LASE (5273) ext. 225
rwhite@theralase.com
www.theralase.com

SOURCE: Theralase Technologies Inc.

ReleaseID: 442971